Open access · OA
via Europe PMC
Urolithins in clinical translation: from gut microbial metabolites to precision interventions.
Frontiers in nutrition · 2026
Dysbiosis
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Human
Review
Abstract
Urolithins are gut microbiota-derived metabolites generated from ellagitannins and ellagic acid, and have emerged as promising mediators at the diet-microbiota-host interface. Interest in this metabolite family has increased substantially owing to growing evidence that urolithins, particularly urolithin A, influence mitochondrial quality control, autophagy(definition), inflammatory signaling, and metabolic homeostasis across multiple tissues. These mechanistic properties have positioned urolithins as candidate interventions for aging-related functional decline, cardiometabolic disorders, neuroinflammatory conditions, and other chronic diseases characterized by impaired cellular resilience. However, their path to clinical application remains incompletely defined. In this Review, we synthesize current knowledge on the origin, microbial biotransformation, metabotypes, pharmacokinetics, and exposure biology of urolithins, with particular attention to the determinants of interindividual variability and the unresolved question of which molecular species are truly active <i>in vivo</i>. We then examine the core mechanisms of urolithin action and evaluate evidence across major disease contexts, integrating pre-clinical findings with available human data. Particular emphasis is placed on the current clinical literature on urolithin A, including safety, tolerability, dosing, target-engagement biomarkers, and functional endpoints. We further analyze the major factors underlying the translational gap between experimental promise and clinical outcomes, including differences in microbial production capacity, free vs. conjugated molecular forms, exposure-response uncertainty, responder heterogeneity, and limitations in trial design. Finally, we discuss how metabotype-guided stratification, microbiome-targeted strategies, improved formulations, and standardized biomarkers may support the development of urolithins within precision nutrition and translational medicine. Collectively, urolithins represent a compelling yet still evolving class of diet-derived microbial metabolites whose clinical utility will depend on resolving key mechanistic, pharmacological, and methodological uncertainties.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fnut.2026.1854240
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
L, H., Y, L., & W., J. (2026). Urolithins in clinical translation: from gut microbial metabolites to precision interventions. <em>Frontiers in nutrition</em>. https://doi.org/10.3389/fnut.2026.1854240
Vancouver
L H, Y L, W. J. Urolithins in clinical translation: from gut microbial metabolites to precision interventions. Frontiers in nutrition. 2026. doi:10.3389/fnut.2026.1854240.
BibTeX
@article{hu2026Urolit,
title = {Urolithins in clinical translation: from gut microbial metabolites to precision interventions.},
author = {Hu L and Ling Y and Jin W.},
journal = {Frontiers in nutrition},
year = {2026},
doi = {10.3389/fnut.2026.1854240},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Nutrition 2026
Open access · CC-BY
Urolithins in clinical translation: from gut microbial metabolites to precision interventions
Reproductive sciences (Thousand Oaks, Calif.) 2026
Citation only
Dual Roles of Autophagy in Endometrial Fibrosis and Its Implications in Age-Related Reproductive Dysfunction.
Stresses 2026
Open access · CC-BY
Hormetic Stress Responses in Aging: From Molecular Mechanisms to Clinical Translation
Bioactive Compounds in Health and Disease 2026
Open access · CC-BY
Food bioactives as modulators of autophagy and mitophagy ininflammaging and healthy aging
Journal of ovarian research 2026
Open access · OA
Research progress on multi-mechanism analysis and protection strategies of ovarian aging and fertility decline.
Pharmaceutics 2026
Open access · OA